Smoking: The percentage of patients in high risk groups whose notes record smoking status and the offer of support and treatment within preceding 15 months [composite]. |
Chronic Obstructive Pulmonary Disease (COPD): Diagnosis of COPD, through use of spirometry and chest radiograph [composite]. |
Chronic Kidney Disease (CKD): The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an ACE-inhibitor or angiotensin receptor blocker. |
Chronic Kidney Disease (CKD): Measurement of blood pressure, urinary protein excretion, and lifestyle advice [composite]. |
Chronic Kidney Disease (CKD): blood pressure and urinary protein excretion targets, and appropriate drug therapy [composite]. |
Myocardial infarction (MI): All patients who have had an acute MI should be offered specific combination drug treatment. |
Chronic heart failure: Measurement of serum natriuretic peptides and referral where appropriate [composite]. |
Atrial fibrillation (AF): recommendations concerning use of anti-coagulants in AF [composite]. |
Hypertension: blood pressure targets in those under/over 80 years of age [composite]. |
Hypertension: lifestyle advice and monitoring of cholesterol and urinary protein excretion [composite]. |
Type 2 diabetes: 9 annual processes of care i.e. measurement of blood pressure, lipids, renal function, urine albumin-creatinine ratio (ACR), glycaemic control, BMI, smoking status, plus foot and eye checks [composite]. |
Type 2 diabetes: Integrate dietary advice with a personalised diabetes management plan. |
Type 2 diabetes: Cardiovascular risk assessment and subsequent statin therapy where indicated. |
Type 2 diabetes: Achievement of target levels for blood pressure, cholesterol and glycaemic control [composite]. |
Type 2 diabetes: For a person on dual therapy who is markedly hyperglycaemic, consider starting insulin therapy in preference to adding other drugs to control blood glucose. |
Diabetes mellitus: The percentage of patients with diabetes in whom the last blood pressure is ≤ 140/80 mmHg. |
Non-steroidal anti-inflammatory drugs (NSAIDs): Use of NSAIDs and monitoring of potential side-effects [composite]. |
Depression in adults: Recommendations concerning severity-appropriate treatment of depression [composite]. |